81_FR_66226 81 FR 66040 - Supplement for Zika Response, a Single-Award Deviation From Competition Requirements for the National Center for Medical Home Implementation Cooperative Agreement

81 FR 66040 - Supplement for Zika Response, a Single-Award Deviation From Competition Requirements for the National Center for Medical Home Implementation Cooperative Agreement

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration

Federal Register Volume 81, Issue 186 (September 26, 2016)

Page Range66040-66041
FR Document2016-23096

HRSA announces the award of a supplement in the amount of $350,000 for the National Center for Medical Home Implementation (NCMHI) cooperative agreement. The purpose of the NCMHI cooperative agreement is to support a national resource and assistance effort to implement and spread the medical home model to all children and youth, particularly children with special health care needs (CSHCN), children who are vulnerable and/or medically underserved, and pediatric populations served by state public health programs, the Maternal and Child Health Bureau (MCHB), and HRSA. The supplement will permit the American Academy of Pediatrics (AAP), the cooperative agreement awardee, during the budget period of July 1, 2016-June 30, 2017, to enhance their capacity to provide technical assistance and health professional education to increase the clinical expertise of pediatric health care professionals, including safety net providers, to more effectively serve as the medical home and provide family-centered, comprehensive, coordinated, and culturally-effective care for Zika- affected children and their families.

Federal Register, Volume 81 Issue 186 (Monday, September 26, 2016) 
[Federal Register Volume 81, Number 186 (Monday, September 26, 2016)]
[Notices]
[Pages 66040-66041]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-23096]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Supplement for Zika Response, a Single-Award Deviation From 
Competition Requirements for the National Center for Medical Home 
Implementation Cooperative Agreement

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: HRSA announces the award of a supplement in the amount of 
$350,000 for the National Center for Medical Home Implementation 
(NCMHI) cooperative agreement. The purpose of the NCMHI cooperative 
agreement is to support a national resource and assistance effort to 
implement and spread the medical home model to all children and youth, 
particularly children with special health care needs (CSHCN), children 
who are vulnerable and/or medically underserved, and pediatric 
populations served by state public health programs, the Maternal and 
Child Health Bureau (MCHB), and HRSA. The supplement will permit the 
American Academy of Pediatrics (AAP), the cooperative agreement 
awardee, during the budget period of July 1, 2016-June 30, 2017, to 
enhance their capacity to provide technical assistance and health 
professional education to increase the clinical expertise of pediatric 
health care professionals, including safety net providers, to more 
effectively serve as the medical home and provide family-centered, 
comprehensive, coordinated, and culturally-effective care for Zika-
affected children and their families.

FOR FURTHER INFORMATION CONTACT: Marie Y. Mann, MD, MPH, FAAP, Division 
of Services for Children with Special Health Needs, Maternal and Child 
Health Bureau, Health Resources and Services Administration, 5600 
Fishers Lane, Room 18W61, Rockville, Maryland 20857; [email protected].

SUPPLEMENTARY INFORMATION: 
    Intended Recipient of the Award: The American Academy of 
Pediatrics.
    Amount of Non-Competitive Awards: $350,000.
    Period of Supplemental Funding: 7/1/2016-6/30/2017.
    CFDA Number: 93.110.

    Authority:  Social Security Act, Title V, sections 501(a)(1)(D) 
and 501(a)(2), (42 U.S.C. 701(a)(1)(D) and 701(a)(2))

    Justification: Zika virus infection during pregnancy dramatically 
increases the risk of birth defects. Microcephaly has been linked to 
Zika virus infection during pregnancy, and the extent of other possible 
birth defects is unclear. As of August 25, 2016, there are 624 pregnant 
women in the 50 states and the District of Columbia reported to have 
the Zika virus infection. In Puerto Rico, over 600 pregnant women have 
been reported to have the Zika virus infection as a result of exposure 
to the Zika virus during pregnancy. However, pediatric specialty 
expertise to care for their babies is limited. Currently, no network 
exists to link providers caring for these patients with those who have 
relevant expertise or experience in managing infants and children of 
women exposed to Zika virus during pregnancy. Discussions of 
developmental screening, clinical management, and family support 
approaches will help clinicians serving this population, thereby 
increasing access to well-coordinated, family-centered care and 
management in a medical home for children and families impacted by 
Zika-related complications.
    The purpose of the NCMHI cooperative agreement is to support a 
national resource and assistance effort to implement and spread the 
medical home model to all children and youth, particularly CSHCN, 
children who are vulnerable and/or medically underserved, and pediatric 
populations served by state public health programs, MCHB, and HRSA. In 
2013, following objective review of its competitive application, HRSA 
awarded the NCMHI cooperative agreement to AAP, a nonprofit, tax-exempt 
organization under Internal Revenue Code 501(c)(3).
    This supplement to the NCMHI cooperative agreement provides 
technical assistance and education, including tele-mentoring, to 
clinicians providing care for children who are or may be impacted by 
Zika at HRSA-supported health centers and elsewhere within the United 
States (including U.S. territories and jurisdictions). Using the tele-
mentoring technology, clinicians will team with specialists elsewhere 
to provide clinicians with the tools and resources to improve care 
delivery within the medical home, thereby increasing the sustainability 
of the medical home model for children affected by Zika. Though 
available to all clinicians, technical assistance and education will be 
directed primarily toward pediatric primary care physicians in areas at 
high-risk for Zika and toward clinicians operating in health centers 
supported by HRSA's Bureau of Primary Health Care. These activities 
will provide critical knowledge to health care professionals, including 
safety net providers, to more effectively serve as the medical home for 
children affected by Zika and their families.

----------------------------------------------------------------------------------------------------------------
                                                                                                     FY 2016
                                                                                    FY 2016         estimated
          Grantee/organization name              Grant No.          State          authorized      funding for
                                                                                 funding level   this supplement
----------------------------------------------------------------------------------------------------------------
The American Academy of Pediatrics..........            U43MC09134         IL       $1,300,031         $350,000
----------------------------------------------------------------------------------------------------------------



[[Page 66041]]

    Dated: September 19, 2016.
James Macrae,
Acting Administrator.
[FR Doc. 2016-23096 Filed 9-23-16; 8:45 am]
 BILLING CODE 4165-15-P

66040 Federal Register / Vol. 81, No. 186 / Monday, September 26, 2016 / Notices SUPPLEMENTARY INFORMATION: In the the Maternal and Child Health Bureau to Zika virus during pregnancy. Federal Register of Monday, September (MCHB), and HRSA. The supplement Discussions of developmental screening, 19, 2016, in FR Doc. 2016–22470, on will permit the American Academy of clinical management, and family page 64178 the following correction is Pediatrics (AAP), the cooperative support approaches will help clinicians made: agreement awardee, during the budget serving this population, thereby On page 64178, in the second column, period of July 1, 2016–June 30, 2017, to increasing access to well-coordinated, in the last sentence of the first enhance their capacity to provide family-centered care and management paragraph under Section I, Background, technical assistance and health in a medical home for children and ‘‘Biomarkers Used as Outcomes in professional education to increase the families impacted by Zika-related Development of FDA-Approved clinical expertise of pediatric health complications. Therapeutics (October 2007 to care professionals, including safety net The purpose of the NCMHI December 2015)’’ is corrected to read providers, to more effectively serve as cooperative agreement is to support a ‘‘http://www.fda.gov/Drugs/ the medical home and provide family- national resource and assistance effort DevelopmentApprovalProcess/Drug centered, comprehensive, coordinated, to implement and spread the medical DevelopmentToolsQualification and culturally-effective care for Zika- home model to all children and youth, Program/ucm483052.htm’’. affected children and their families. particularly CSHCN, children who are Dated: September 21, 2016. FOR FURTHER INFORMATION CONTACT: vulnerable and/or medically Leslie Kux, Marie Y. Mann, MD, MPH, FAAP, underserved, and pediatric populations Associate Commissioner for Policy. Division of Services for Children with served by state public health programs, [FR Doc. 2016–23106 Filed 9–23–16; 8:45 am] Special Health Needs, Maternal and MCHB, and HRSA. In 2013, following Child Health Bureau, Health Resources objective review of its competitive BILLING CODE 4164–01–P and Services Administration, 5600 application, HRSA awarded the NCMHI Fishers Lane, Room 18W61, Rockville, cooperative agreement to AAP, a DEPARTMENT OF HEALTH AND Maryland 20857; MMann@hrsa.gov. nonprofit, tax-exempt organization HUMAN SERVICES SUPPLEMENTARY INFORMATION: under Internal Revenue Code 501(c)(3). Intended Recipient of the Award: The This supplement to the NCMHI Health Resources and Services American Academy of Pediatrics. cooperative agreement provides Administration Amount of Non-Competitive Awards: technical assistance and education, $350,000. including tele-mentoring, to clinicians Supplement for Zika Response, a Period of Supplemental Funding: providing care for children who are or Single-Award Deviation From 7/1/2016–6/30/2017. may be impacted by Zika at HRSA- Competition Requirements for the CFDA Number: 93.110. supported health centers and elsewhere National Center for Medical Home Authority: Social Security Act, Title V, within the United States (including U.S. Implementation Cooperative sections 501(a)(1)(D) and 501(a)(2), (42 U.S.C. territories and jurisdictions). Using the Agreement 701(a)(1)(D) and 701(a)(2)) tele-mentoring technology, clinicians AGENCY: Health Resources and Services Justification: Zika virus infection will team with specialists elsewhere to Administration (HRSA), Department of during pregnancy dramatically increases provide clinicians with the tools and Health and Human Services (HHS). the risk of birth defects. Microcephaly resources to improve care delivery ACTION: Notice. has been linked to Zika virus infection within the medical home, thereby during pregnancy, and the extent of increasing the sustainability of the SUMMARY: HRSA announces the award other possible birth defects is unclear. medical home model for children of a supplement in the amount of As of August 25, 2016, there are 624 affected by Zika. Though available to all $350,000 for the National Center for pregnant women in the 50 states and the clinicians, technical assistance and Medical Home Implementation District of Columbia reported to have education will be directed primarily (NCMHI) cooperative agreement. The the Zika virus infection. In Puerto Rico, toward pediatric primary care purpose of the NCMHI cooperative over 600 pregnant women have been physicians in areas at high-risk for Zika agreement is to support a national reported to have the Zika virus infection and toward clinicians operating in resource and assistance effort to as a result of exposure to the Zika virus health centers supported by HRSA’s implement and spread the medical during pregnancy. However, pediatric Bureau of Primary Health Care. These home model to all children and youth, specialty expertise to care for their activities will provide critical particularly children with special health babies is limited. Currently, no network knowledge to health care professionals, care needs (CSHCN), children who are exists to link providers caring for these including safety net providers, to more vulnerable and/or medically patients with those who have relevant effectively serve as the medical home underserved, and pediatric populations expertise or experience in managing for children affected by Zika and their served by state public health programs, infants and children of women exposed families. FY 2016 FY 2016 estimated Grantee/organization name Grant No. State authorized funding for this funding level supplement mstockstill on DSK3G9T082PROD with NOTICES The American Academy of Pediatrics ............................................................. U43MC09134 IL $1,300,031 $350,000 VerDate Sep<11>2014 19:40 Sep 23, 2016 Jkt 238001 PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 E:\FR\FM\26SEN1.SGM 26SEN1

Federal Register / Vol. 81, No. 186 / Monday, September 26, 2016 / Notices 66041 Dated: September 19, 2016. DEPARTMENT OF HEALTH AND The meeting will be closed to the James Macrae, HUMAN SERVICES public in accordance with the Acting Administrator. provisions set forth in sections National Institutes of Health 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., [FR Doc. 2016–23096 Filed 9–23–16; 8:45 am] as amended. The grant applications and BILLING CODE 4165–15–P National Institute of Allergy and the discussions could disclose Infectious Diseases; Notice of Closed confidential trade secrets or commercial Meeting property such as patentable material, DEPARTMENT OF HEALTH AND Pursuant to section 10(d) of the and personal information concerning HUMAN SERVICES individuals associated with the grant Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is applications, the disclosure of which National Institutes of Health hereby given of the following meeting. would constitute a clearly unwarranted National Institute of Allergy And invasion of personal privacy. The meeting will be closed to the Infectious Diseases; Notice of Closed public in accordance with the Name of Committee: Allergy, Immunology, Meeting provisions set forth in sections and Transplantation Research Committee. Date: October 20, 2016. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Time: 10:00 a.m. to 6:00 p.m. Pursuant to section 10(d) of the as amended. The grant applications and Agenda: To review and evaluate grant Federal Advisory Committee Act, as the discussions could disclose applications amended (5 U.S.C. App.), notice is confidential trade secrets or commercial Place: National Institutes of Health, 5601 hereby given of the following meeting. property such as patentable material, Fishers Lane, Rockville, MD 20892 and personal information concerning (Telephone Conference Call). The meeting will be closed to the Contact Person: James T. Snyder, Ph.D., public in accordance with the individuals associated with the grant applications, the disclosure of which Scientific Review Officer Scientific Review provisions set forth in sections Program, Division of Extramural Activities/ would constitute a clearly unwarranted Room 3G31B, National Institutes of Health, 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., invasion of personal privacy. NIAID, 5601 Fishers Lane, MSC 9834, as amended. The grant applications and Name of Committee: National Institute of Bethesda, MD 20892–9834, (240) 669–5060, the discussions could disclose Allergy and Infectious Diseases Special james.snyder@nih.gov. confidential trade secrets or commercial Emphasis Panel; RAPID ASSESSMENT OF (Catalogue of Federal Domestic Assistance property such as patentable material, ZIKA VIRUS (ZIKV) COMPLICATIONS Program Nos. 93.855, Allergy, Immunology, and personal information concerning (R21). and Transplantation Research; 93.856, individuals associated with the grant Date: October 20, 2016. Microbiology and Infectious Diseases applications, the disclosure of which Time: 8:30 a.m. to 6:00 p.m. Research, National Institutes of Health, HHS) would constitute a clearly unwarranted Agenda: To review and evaluate grant Dated: September 19, 2016. invasion of personal privacy. applications. Natasha M. Copeland, Place: National Institutes of Health, 5601 Name of Committee: National Institute of Fishers Lane, Rockville, MD 20892 Program Analyst, Office of Federal Advisory Allergy and Infectious Diseases Special (Telephone Conference Call). Committee Policy. Emphasis Panel; NIAID Investigator Initiated Contact Person: Jay R. Radke, Ph.D., [FR Doc. 2016–23140 Filed 9–23–16; 8:45 am] Program Project Applications (P01). Scientific Review Officer, Scientific Review BILLING CODE 4140–01–P Date: October 18, 2016. Program, Division of Extramural Activities, Time: 1:30 p.m. to 4:30 p.m. Room #3G11B, National Institutes of Health, Agenda: To review and evaluate grant NIAID, 5601 Fishers Lane, MSC–9823, DEPARTMENT OF HEALTH AND Bethesda, MD 20892–9823, (240) 669–5046, HUMAN SERVICES applications. jay.radke@nih.gov. Place: National Institutes of Health, 5601 (Catalogue of Federal Domestic Assistance National Institutes of Health Fishers Lane, Rockville, MD 20892 Program Nos. 93.855, Allergy, Immunology, (Telephone Conference Call). and Transplantation Research; 93.856, National Heart, Lung, and Blood Contact Person: James T. Snyder, Ph.D., Microbiology and Infectious Diseases Institute, Notice of Meeting Scientific Review Officer, Scientific Review Research, National Institutes of Health, HHS) Program, Division of Extramural Activities/ Pursuant to section 10(d) of the Dated: September 21, 2016. Room 3G31B, National Institutes of Health, Federal Advisory Committee Act, as NIAID, 5601 Fishers Lane MSC 9823, Natasha M. Copeland, amended (5 U.S.C. App.), notice is Rockville, MD 20892, (240) 669–5060, Program Analyst, Office of Federal Advisory hereby given of a meeting of the james.snyder@nih.gov. Committee Policy. National Heart, Lung, and Blood (Catalogue of Federal Domestic Assistance [FR Doc. 2016–23142 Filed 9–23–16; 8:45 am] Advisory Council. Program Nos. 93.855, Allergy, Immunology, BILLING CODE 4140–01–P The meeting will be open to the and Transplantation Research; 93.856, public as indicated below, with Microbiology and Infectious Diseases attendance limited to space available. Research, National Institutes of Health, HHS) DEPARTMENT OF HEALTH AND Individuals who plan to attend and HUMAN SERVICES need special assistance, such as sign Dated: September 21, 2016. language interpretation or other Natasha M. Copeland, National Institutes of Health reasonable accommodations, should Program Analyst, Office of Federal Advisory notify the Contact Person listed below mstockstill on DSK3G9T082PROD with NOTICES Committee Policy. National Institute of Allergy and Infectious Diseases; Notice of Closed in advance of the meeting. [FR Doc. 2016–23139 Filed 9–23–16; 8:45 am] Meeting The meeting will be closed to the BILLING CODE 4140–01–P public in accordance with the Pursuant to section 10(d) of the provisions set forth in sections Federal Advisory Committee Act, as 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., amended (5 U.S.C. App.), notice is as amended. The grant applications and hereby given of the following meeting. the discussions could disclose VerDate Sep<11>2014 19:40 Sep 23, 2016 Jkt 238001 PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 E:\FR\FM\26SEN1.SGM 26SEN1


Document Created: 2018-02-09 13:22:52
Document Modified: 2018-02-09 13:22:52
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice.
ContactMarie Y. Mann, MD, MPH, FAAP, Division of Services for Children with Special Health Needs, Maternal and Child Health Bureau, Health Resources and Services Administration, 5600 Fishers Lane, Room 18W61, Rockville, Maryland 20857; [email protected]
FR Citation81 FR 66040 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR